Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Completion of phase II Friedreich's ataxia study of idebenone

Oct. 11, 2006

Rotigotine transdermal patch yields reduction in RLS symptoms

Oct. 11, 2006

Recent patents report new treatments for depression, psychosis, sleep disorders, etc.

Oct. 10, 2006

Myodur IND for Duchenne muscular dystrophy remains on hold

Oct. 10, 2006

Approvable letter for NRP-104 in ADHD

Oct. 10, 2006

Brivaracetam to enter clinical trials as an add-on therapy for Unverricht-Lundborg disease

Oct. 10, 2006

Phase IIb adrenomyeloneuropathy study of RPI-78M cleared to begin

Oct. 10, 2006

Risperdal approved for irritability associated with autistic disorder

Oct. 9, 2006

Swedish approval for phase IIa study of PBT-2 in early Alzheimer's disease

Oct. 9, 2006

Traditional Indian phytotherapy shows potential in AD therapy

Oct. 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...